Cargando…
Zeta Inhibitory Peptide as a Novel Therapy to Control Chronic Visceral Hypersensitivity in a Rat Model
BACKGROUND: The pathogenesis of multiple chronic visceral pain syndromes, such as irritable bowel syndrome (IBS), is not well known, and as a result current therapies are ineffective. The objective of this study was to investigate the effect of spinal protein kinase M zeta (PKMζ) on visceral pain se...
Autores principales: | Tang, Ying, Chen, Aiqin, Chen, Yu, Guo, Lixia, Dai, Hengfen, Huang, Yang, Chen, Qianqian, Lin, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077089/ https://www.ncbi.nlm.nih.gov/pubmed/27776136 http://dx.doi.org/10.1371/journal.pone.0163324 |
Ejemplares similares
-
Blockade of BDNF signalling attenuates chronic visceral hypersensitivity in an IBS‐like rat model
por: Fan, Fei, et al.
Publicado: (2020) -
Involvement of protein kinase ζ in the maintenance of hippocampal long-term potentiation in rats with chronic visceral hypersensitivity
por: Chen, Aiqin, et al.
Publicado: (2015) -
Contribution of Amygdala Histone Acetylation in Early Life Stress-Induced Visceral Hypersensitivity and Emotional Comorbidity
por: Guan, Le, et al.
Publicado: (2022) -
Hippocampal Infusion of Zeta Inhibitory Peptide Impairs Recent, but Not Remote, Recognition Memory in Rats
por: Hales, Jena B., et al.
Publicado: (2015) -
Blockade of BK channels attenuates chronic visceral hypersensitivity
in an IBS-like rat model
por: Fan, F, et al.
Publicado: (2021)